Evidence map›Paper›PMID 25785992›Full record

ArticlePloS one2015

Magnetic resonance imaging assessment of effective ablated volume following high intensity focused ultrasound.

Brett Z Fite, Andrew Wong, Yu Liu, Lisa M Mahakian, Sarah M Tam, Olulanu Aina, Neil E Hubbard, Alexander Borowsky, Robert D Cardiff, Erik Dumont and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. T2 mapping as a predictor of nonperfused volume in MRgFUS treatment of desmoid tumors.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2019
    Article
  7. Article
  8. Focused Ultrasound Effects on Osteosarcoma Cell Lines.BioMed research international · 2019
    Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Brett Z FiteDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
Andrew WongDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
Yu LiuDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
Lisa M MahakianDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
Sarah M TamDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
Olulanu AinaCenter for Comparative Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Neil E HubbardCenter for Comparative Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Alexander BorowskyCenter for Comparative Medicine, University of California Davis, Davis, CA, 95616, United States of America; Department of Pathology and Laboratory Medicine, School of Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Robert D CardiffCenter for Comparative Medicine, University of California Davis, Davis, CA, 95616, United States of America; Department of Pathology and Laboratory Medicine, School of Medicine, University of California Davis, Davis, CA, 95616, United States of America.
Erik DumontImage Guided Therapy, Pessac, France.
Katherine W FerraraDepartment of Biomedical Engineering, University of California Davis, Davis, CA, 95616, United States of America.
University of California, Davis · USInstitut de Chirurgie Guidée par l'Image · FR

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
Ultrasound Imaging and Local Drug Delivery in TumorsR01CA103828 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W · 2004 to 2013
$10.4M
Specific and high-resolution ultrasound cancer imagingR01CA112356 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI FERRARA, KATHERINE W, FOIRET, JOSQUIN · 2005 to 2022
$6.1M
Ultrasound imaging and enhanced therapeutic responseR01CA134659 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FERRARA, KATHERINE W · 2009 to 2017
$4.4M
The Center for Translational Genomic PhenotypingU01CA141582 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CARDIFF, ROBERT D, CHERRY, SIMON R · 2009 to 2013
$3.5M
NCI NIH HHS R01 CA103828NCI NIH HHS R01CA103828NCI NIH HHS R01 CA134659NCI NIH HHS R01CA134659NCI NIH HHS U01 CA141582
6 · The paper itself

Abstract

Under magnetic resonance (MR) guidance, high intensity focused ultrasound (HIFU) is capable of precise and accurate delivery of thermal dose to tissues. Given the excellent soft tissue imaging capabilities of MRI, but the lack of data on the correlation of MRI findings to histology following HIFU, we sought to examine tumor response to HIFU ablation to determine whether there was a correlation between histological findings and common MR imaging protocols in the assessment of the extent of thermal damage. Female FVB mice (n = 34), bearing bilateral neu deletion tumors, were unilaterally insonated under MR guidance, with the contralateral tumor as a control. Between one and five spots (focal size 0.5 × 0.5 × 2.5 mm3) were insonated per tumor with each spot receiving approximately 74.2 J of acoustic energy over a period of 7 seconds. Animals were then imaged on a 7T MR scanner with several protocols. T1 weighted images (with and without gadolinium contrast) were collected in addition to a series of T2 weighted and diffusion weighted images (for later reconstruction into T2 and apparent diffusion coefficient maps), immediately following ablation and at 6, 24, and 48 hours post treatment. Animals were sacrificed at each time point and both insonated/treated and contralateral tumors removed and stained for NADH-diaphorase, caspase 3, or with hematoxylin and eosin (H&E). We found the area of non-enhancement on contrast enhanced T1 weighted imaging immediately post ablation correlated with the region of tissue receiving a thermal dose CEM43 ≥ 240 min. Moreover, while both tumor T2 and apparent diffusion coefficient values changed from pre-ablation values, contrast enhanced T1 weighted images appeared to be more senstive to changes in tissue viability following HIFU ablation.

Indexed as

AdenocarcinomaAnimalsCell Line, TumorContrast MediaDiffusion Magnetic Resonance ImagingFemaleGadoliniumHigh-Intensity Focused Ultrasound AblationHistocytochemistryImage Processing, Computer-AssistedMammary Neoplasms, ExperimentalMiceSoundSurgery, Computer-AssistedTumor BurdenContrast MediaGadolinium

Identifiers

PMID25785992
PMCPMC4365027
OpenAlexW2045574472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.